Lyfgenia Suspension
Product Images NDC 73554-1111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lyfgenia (NDC 73554-1111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genetix Biotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lyfgenia Package Label (Lyfgenia 03)

Lyfgenia Package Label (Lyfgenia 03)
This is a description for a suspension for IV infusion containing genetically modified autologous hematopoietic stem cells. The suspension is in a cryopreservation solution containing 5% DMSO. It is meant for autologous use only and should be used intravenously. The suspension is stored in metal cassettes in the vapor phase of liquid nitrogen at a temperature below -140°C until ready for thawing and administration. The text mentions that it should not be re-frozen once thawed and should not be irradiated. It also states that it has not been evaluated for infectious substances and does not contain preservatives. The full prescribing information for dosage and administration can provide more details. The text also mentions the need to confirm patient identifiers such as last name, first name, date of birth, patient ID, and COL ID. The manufacturer mentioned is bluebird bio, Inc., located in Somerville, MA. The contact number provided is 1-833-999-6378.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.